[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334055-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-334055-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","circulating-phylloquinone-and-the-risk-of-four-female-specific-cancers-a-mendelian-randomization-study","Circulating Phylloquinone and the Risk of Four Female-Specific Cancers - A Mendelian Randomization Study","","Observational research links vitamin K with cancer, yet whether the association is causal remains unclear. This Mendelian randomization study evaluates the relationship between circulating phylloquinone (vitamin K1) levels and four female-specific cancers. Genetic instruments based on four SNPs were applied, with instrument strength assessed by reported F-statistics. SNP–outcome associations were drawn from consortium meta-analyses, UK Biobank, and FinnGen, and multiple complementary MR methods were used to address pleiotropy. Results consistently supported no causal association, with null findings across sensitivity analyses, including MR-PRESSO and MR Egger assessments, and no outlying variants detected.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/circulating-phylloquinone-and-the-risk-of-four-female-specific-cancers-a-mendelian-randomization-study/334055/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/circulating-phylloquinone-and-the-risk-of-four-female-specific-cancers-a-mendelian-randomization-study/334055.png","ImageObject",300,407,{"name":42,"@type":43},"Skyler","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about vitamin K and cancer?","Question",{"text":63,"@type":64},"The study tests whether circulating phylloquinone (vitamin K1) has a causal effect on the risk of four female-specific cancers, since observational links do not establish causality.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were circulating phylloquinone levels instrumented in the Mendelian randomization analysis?",{"text":68,"@type":64},"The analysis used four single-nucleotide polymorphisms (SNPs) as genetic instruments for phylloquinone levels, with instrument strength reported using F-statistics.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main findings regarding cancer risk across the four cancers studied?",{"text":72,"@type":64},"The main MR analysis and sensitivity analyses consistently showed a null association between genetically predicted phylloquinone levels and all four cancers, with p-values greater than 0.05 across methods.",{"name":74,"@type":61,"acceptedAnswer":75},"Did the study detect pleiotropy or outlying genetic variants?",{"text":76,"@type":64},"MR Egger and MR-PRESSO results did not indicate horizontal pleiotropy, and MR-PRESSO did not detect outlying variants, with leave-one-out analyses supporting the overall conclusions.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},334055,1790579050,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":148,"preview_page_count":4},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","nutrients   \nArticle  \nCirculating Phylloquinone and the Risk of Four Female-Specific Cancers: A Mendelian Randomization Study  \nMelaku Yalew 1,2,3, Anwar Mulugeta 1,2,4, Amanda L. Lumsden 1,2, Iqbal Madakkatel 1,2, S. Hong Lee 1,2,5, Martin K. Oehler 6,7, Johanna Mäenpää 8,9 and Elina Hyppönen 1,2, *  \nCitation: Yalew, M.; Mulugeta, A.; Lumsden, A.L.; Madakkatel, I.; Lee, S.H.; Oehler, M.K.; Mäenpää, J.; Hyppönen, E. Circulating Phylloquinone and the Risk of Four Female-Specific Cancers: A Mendelian Randomization Study. Nutrients 2024, 16, 3680. [https://](https://)[ ](https://)[doi.org/10.3390/nu16213680](doi.org/10.3390/nu16213680)  \nAcademic Editor: Ahmad R. Heydari  \nReceived: 21 September 2024  \nRevised: 16 October 2024  \nAccepted: 22 October 2024  \nPublished: 29 October 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia  \n2 South Australia Health and Medical Research Institute, Adelaide, SA 5000, Australia  \n3 Department of Public Health, College of Medicine and Health Sciences, Injibara University, Injibara P.O. Box 6040, Ethiopia  \n4 Department of Pharmacology and Clinical Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa P.O. Box 9086, Ethiopia  \n5 UniSA Allied Health & Human Performance, University of South Australia, Adelaide, SA 5001, Australia  \n6 Department of Gynecological Oncology, Royal Adelaide Hospital, Adelaide, SA 5000, Australia; [martin.oehler@adelaide.edu.au](martin.oehler@adelaide.edu.au)  \n7 Adelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide, SA 5006, Australia  \n8 Faculty of Medicine and Medical Technology, Tampere University, 33014 Tampere, Finland  \n9 Cancer Centre, Tampere University and University Hospital, 33520 Tampere, Finland  \n* Correspondence: [elina.hypponen@unisa.edu.au](elina.hypponen@unisa.edu.au); Tel.: +61-(08)-83022518  \nAbstract: Background: Observational studies have linked vitamin K and cancer, but the causality of this association remains unknown. This Mendelian randomization (MR) study aims to investigate the association between circulating phylloquinone (vitamin K 1) levels and four female-specific cancers. Methods: We used four single-nucleotide polymorphisms (SNPs) to instrument phylloquinone, with the reported F-statistic 16.00–28.44 for all variants. SNP–outcome associations were obtained from consortia meta-analyses, UK Biobank, and the FinnGen database (up to 145,257/419,675, 27,446/362,324, 15,181/591,477, and 2211/320,454 cases/controls for breast, ovarian, endometrial, and cervical cancer, respectively) . Analyses were conducted using five complementary MR methods including pleiotropy robust approaches. The MR Egger intercept test, MR PRESSO global test and leave-one-out analyses were used to test for and identify pleiotropic variants. Results: The relevance of the instrument was validated by positive control analyses on coagulation factor IX (p = 0.01) . However, the main MR analysis and all sensitivity analyses were consistently supportive of a null association between phylloquinone and all four cancers (p > 0.05 for all analyses, across all methods) . MR-PRESSO did not detect outlying variants, and there was no evidence of horizontal pleiotropy relating to any cancer outcome (p intercept > 0.26 for all) . Conclusions: We found no evidence for an association between genetically predicted circulating phylloquinone levels and the risk of four female-specific cancers.  \nKeywords: Mendelian randomization; vitamin K1; circulating phylloquinone; female-specific canc","cbCaibwXPf6BKoUX","https://ap.wps.com/l/cbCaibwXPf6BKoUX","pdf",852767,"English","# Abstract\n## Background and aim\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Vitamin K forms and biology\n## Evidence from observational and trials\n## Rationale for Mendelian randomization","[{\"question\":\"What question does the study address about vitamin K and cancer?\",\"answer\":\"The study tests whether circulating phylloquinone (vitamin K1) has a causal effect on the risk of four female-specific cancers, since observational links do not establish causality.\"},{\"question\":\"How were circulating phylloquinone levels instrumented in the Mendelian randomization analysis?\",\"answer\":\"The analysis used four single-nucleotide polymorphisms (SNPs) as genetic instruments for phylloquinone levels, with instrument strength reported using F-statistics.\"},{\"question\":\"What were the main findings regarding cancer risk across the four cancers studied?\",\"answer\":\"The main MR analysis and sensitivity analyses consistently showed a null association between genetically predicted phylloquinone levels and all four cancers, with p-values greater than 0.05 across methods.\"},{\"question\":\"Did the study detect pleiotropy or outlying genetic variants?\",\"answer\":\"MR Egger and MR-PRESSO results did not indicate horizontal pleiotropy, and MR-PRESSO did not detect outlying variants, with leave-one-out analyses supporting the overall conclusions.\"}]","Circulating Phylloquinone and the Risk of Four Female-Specific Cancers - A Mendelian Randomization Study | PDF",1790005150,23]